Lupin Limited (LUPIN.NS)

NSE - NSE Delayed Price. Currency in INR
1,468.30-49.35 (-3.25%)
At close: 6:00 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close1,517.65
Bid0.00 x
Ask1,468.30 x
Day's Range1,455.00 - 1,531.80
52wk Range1,280.00 - 2,129.00
1y Target EstN/A
Market Cap661.99B
P/E Ratio (ttm)25.74
Avg Vol (3m)1,077,850
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Reuters3 months ago

    India's Sun Pharma bets on new products to boost U.S. skincare products growth

    India's largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative U.S. dermatology business, its U.S. chief said. The world's fifth-largest maker of generic drugs was the first among its Indian peers to enter the roughly $5 billion U.S. dermatology space by acquiring a controlling stake in Israel's Taro Pharmaceutical Industries Ltd in 2010.

  • Bloomberg4 months ago

    Indian Pharma Tycoons Foray Into New Drugs to Shore Up Growth

    Indian drugmakers are embarking on a research spending spree to master more complex therapies and their billionaire founders look willing to absorb the costs.

  • Bloomberg6 months ago

    Lupin Pares Losses After Saying FDA Observations Are `Minor'

    Shares of Lupin Ltd., India’s second-biggest drugmaker by market value, pared some of their losses after saying observations made by the U.S. Food and Drug Administration on one of its key factories were ...